4.6 Article

Duration of protection from live attenuated vs. sub unit HSV-2 vaccines in the guinea pig model of genital herpes: Reassessing efficacy using endpoints from clinical trials

Related references

Note: Only part of the references are listed.
Editorial Material Neurosciences

Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link

Ruth F. Itzhaki et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Immunology

Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda

Warren Phipps et al.

JOURNAL OF INFECTIOUS DISEASES (2016)

Review Neurosciences

Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease

Steven A. Harris et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Article Virology

Status of prophylactic and therapeutic genital herpes vaccines

Sita Awasthi et al.

CURRENT OPINION IN VIROLOGY (2014)

Review Immunology

The challenge of developing a herpes simplex virus 2 vaccine

Lesia K. Dropulic et al.

EXPERT REVIEW OF VACCINES (2012)

Article Medicine, General & Internal

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Robert B. Belshe et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)